| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1988Sci...241.1632M |
| P356 | DOI | 10.1126/SCIENCE.2971269 |
| P698 | PubMed publication ID | 2971269 |
| P2093 | author name string | Weissman IL | |
| Lieberman M | |||
| Kaneshima H | |||
| Namikawa R | |||
| McCune JM | |||
| Shultz LD | |||
| P433 | issue | 4873 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | murine model | Q122890741 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1632-1639 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function | |
| P478 | volume | 241 |
| Q35252215 | 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening |
| Q36790058 | 7 Development of Mouse Hematopoietic Lineages |
| Q42742542 | A SCID-hu in vivo model of human Waldenström macroglobulinemia |
| Q36601933 | A Simple Mouse Model for the Study of Human Immunodeficiency Virus |
| Q40437300 | A clinically relevant SCID-hu in vivo model of human multiple myeloma |
| Q61443625 | A framework for the ethical assessment of chimeric animal research involving human neural tissue |
| Q35556088 | A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis. |
| Q45038124 | A humanized mouse model of anaphylactic peanut allergy. |
| Q37070130 | A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens |
| Q47399665 | A mightier mouse with human adaptive immunity |
| Q36969230 | A model for personalized in vivo analysis of human immune responsiveness |
| Q53630555 | A novel SCID mouse model for studying spontaneous metastasis of human lung cancer to human tissue. |
| Q28371858 | A novel peptide aldehyde with activity against human cytomegalovirus in two different in vivo models |
| Q92667638 | A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection |
| Q52046893 | A promising model of primary human immunization in human-scid mouse. |
| Q45230747 | A rat monoclonal anti-(human CD2) and L-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome |
| Q33750950 | A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells |
| Q40113593 | Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease |
| Q38353724 | Activation of the signal transducer and activator of transcription 1 signaling pathway in thymocytes from HIV-1-infected human thymus |
| Q67726985 | Acute humanvs. mouse graftvs. host disease in normal and immunodeficient mice |
| Q74462279 | Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses |
| Q37512281 | Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. |
| Q59126043 | Advanced model systems and tools for basic and translational human immunology |
| Q27008307 | Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice |
| Q38831338 | Allograft Cancer Cell Transplantation in Zebrafish |
| Q79125739 | Alloimmune Injury and Rejection of Human Skin Grafts on Human Peripheral Blood Lymphocyte–Reconstituted Non-Obese Diabetic Severe Combined Immunodeficient β2-Microglobulin-Null Mice |
| Q33559066 | An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life |
| Q44006786 | An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice |
| Q37418688 | An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse |
| Q43788979 | Analysis of autoantibody production in SCID-systemic lupus erythematosus (SLE) chimeras |
| Q26767476 | Animal Models for HIV Cure Research |
| Q26777022 | Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success? |
| Q33957283 | Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors |
| Q34050742 | Animal models for AIDS pathogenesis |
| Q30423656 | Animal models for HIV/AIDS research |
| Q37844065 | Animal models for development of an AIDS vaccine |
| Q36066980 | Animal models of acute myelogenous leukaemia - development, application and future perspectives. |
| Q84251637 | Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells |
| Q36364071 | Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras |
| Q58648259 | Antibody-Conjugated Nanoparticles for Biomedical Applications |
| Q36528798 | Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model |
| Q52056534 | Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells. |
| Q21144657 | Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice |
| Q35650970 | Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. |
| Q33905476 | Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts |
| Q28343930 | Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice |
| Q40487963 | Antiviral therapy in human immunodeficiency virus infections. Current status (Part II). |
| Q92620214 | Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models |
| Q35892241 | Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions |
| Q34372087 | Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders? |
| Q53120483 | Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations. |
| Q71997950 | Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody |
| Q40560708 | Autoimmunity versus allo- and xeno-reactivity in SCID mice |
| Q37390234 | BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection |
| Q36361653 | Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model |
| Q90594756 | Barriers for HIV Cure: The Latent Reservoir |
| Q91607012 | Benefits and limitations of humanized mice in HIV persistence studies |
| Q41905059 | Biological half-life of normal and truncated human IgG3 in scid mice |
| Q40078135 | Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma |
| Q30651272 | Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds |
| Q36948581 | Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines |
| Q39583317 | CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. |
| Q53370464 | CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. |
| Q41047206 | CD34+Thy-1+Lin- stem cells from mobilized peripheral blood |
| Q40401338 | CD34-positive early stages of human T-cell differentiation |
| Q72686894 | CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice |
| Q35892412 | CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus |
| Q38945956 | CXCR4 tropic human immunodeficiency virus type 1 induces an apoptotic cascade in immature infected thymocytes that resembles thymocyte negative selection |
| Q37195155 | Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders? |
| Q37602302 | Cancer stem cells and the cellular hierarchy in haematological malignancies |
| Q37398584 | Cancer stem cells: relevance to SCT |
| Q33801683 | Chapter 12. Placental remodeling of the uterine vasculature |
| Q35598496 | Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope |
| Q35832063 | Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease |
| Q83133198 | Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice |
| Q33736043 | Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation |
| Q63363252 | Characterization of γ/δ T cell clones isolated from human fetal liverand thymus |
| Q38666256 | Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities. |
| Q84040857 | Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice |
| Q37055410 | Common themes in microbial pathogenicity |
| Q36194697 | Comparative animal models for the study of lymphohematopoietic tumors: strengths and limitations of present approaches |
| Q39971262 | Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice |
| Q46097971 | Comparison of strategies to detect and quantitate uniquely marked cells in intra- and inter-species hemopoietic chimeras |
| Q50788309 | Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice. |
| Q40656354 | Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model |
| Q27022477 | Concise review: humanized models of tumor immunology in the 21st century: convergence of cancer research and tissue engineering |
| Q30664978 | Conserved and divergent aspects of human T-cell development and migration in humanized mice |
| Q36671440 | Cord blood stem and progenitor cells |
| Q45869865 | Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation |
| Q47606345 | Current Progress in EBV-Associated B-Cell Lymphomas |
| Q33577361 | Current advances in humanized mouse models |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q36042986 | Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease |
| Q41013991 | Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice |
| Q36355613 | Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model |
| Q33854835 | Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status |
| Q35039896 | Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation |
| Q41322386 | Deficiency in T cell responses of human fetal lymph node cells: a lack of accessory cells |
| Q38749141 | Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies |
| Q34994838 | Detection of human hematopoietic stem cell engraftment in the livers of adult immunodeficient mice by an optimized flow cytometric method |
| Q38884521 | Development of Humanized Mice in the Age of Genome Editing. |
| Q60048505 | Development of Severe Combined Immunodeficient (SCID) Pig Models for Translational Cancer Modeling: Future Insights on How Humanized SCID Pigs Can Improve Preclinical Cancer Research |
| Q70527007 | Development of T cell receptor alpha beta-bearing T cells in the submersion organ culture of murine fetal thymus at high oxygen concentration |
| Q35159582 | Development of a vaccine for the prevention of AIDS, a critical appraisal |
| Q34931908 | Development of alphabeta T cells in the human thymus |
| Q24669724 | Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice |
| Q36016352 | Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice |
| Q33908298 | Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients |
| Q52179231 | Differential effects of CD4+ and CD8+ cells on lymphocyte development from human cord blood cells in murine fetal thymus explants. |
| Q67993236 | Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations |
| Q36361993 | Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate |
| Q48276056 | Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice |
| Q39796195 | Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cells |
| Q36816122 | Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo |
| Q40146856 | Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells |
| Q41493097 | Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice |
| Q72097885 | Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model |
| Q71617657 | Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4 |
| Q51167248 | End-stage organ failure: will regenerative medicine keep its promise? |
| Q30974719 | Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice |
| Q26745978 | Engineering approaches for regeneration of T lymphopoiesis |
| Q33844310 | Engineering humanized mice for improved hematopoietic reconstitution |
| Q34066833 | Engineering the human thymic microenvironment to support thymopoiesis in vivo |
| Q67898702 | Engraftment and Development of Human T and B Cells in Mice After Bone Marrow Transplantation |
| Q35600543 | Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero |
| Q35891607 | Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF. |
| Q40979773 | Engraftment of myasthenia gravis thymocytes into severe combined immunodeficiency (SCID) mice |
| Q37273984 | Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations |
| Q54707671 | Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen. |
| Q41704288 | Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man |
| Q37147232 | Establishing humanized mice using stem cells: maximizing the potential |
| Q39783316 | Establishment and maintenance of HIV latency: model systems and opportunities for intervention |
| Q41736124 | Establishment of Theileria-infected bovine cell lines in scid mice |
| Q40706072 | Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice |
| Q72412152 | Establishment of human IgE system in severe combined immunodeficient mice with peripheral blood mononuclear cells from asthmatic children |
| Q33581952 | Ethics of fetal tissue transplantation |
| Q41820518 | Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model |
| Q27318356 | Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice |
| Q36708954 | Experimental approaches to the study of HIV-1 latency |
| Q54121855 | Experimental studies on immunosuppression: how do they predict for man? |
| Q36375588 | Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice |
| Q24529578 | Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1. |
| Q33911359 | Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells |
| Q33350230 | Failure of blood mononuclear cells from human donors with autoimmune haemolytic anaemia to reconstitute severe combined immunodeficient mice |
| Q33742501 | Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome |
| Q37634024 | Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease |
| Q36915916 | FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo |
| Q38572329 | Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis |
| Q26864024 | From Beta cell replacement to beta cell regeneration: implications for antidiabetic therapy |
| Q34527769 | Frontier of therapeutic antibody discovery: The challenges and how to face them |
| Q74180150 | Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells |
| Q39590030 | Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. |
| Q74471526 | Furry flasks? |
| Q40497122 | Future prospects for animal models created by transplanting human haematopoietic cells into immune-deficient mice. |
| Q27022347 | Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice |
| Q46361829 | Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice |
| Q34023762 | Generation of Rat Pancreas in Mouse by Interspecific Blastocyst Injection of Pluripotent Stem Cells |
| Q39923037 | Generation of T lineage cells from human embryonic stem cells in a feeder free system |
| Q36357115 | Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice |
| Q39997497 | Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method |
| Q34135605 | Generation of improved humanized mouse models for human infectious diseases |
| Q73308236 | Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice |
| Q36437963 | Giant cell vasculitis is a T cell-dependent disease |
| Q37969755 | Granuloma transplantation: an approach to study mycobacterium-host interactions |
| Q41689649 | Growth factors and hematopoietic stem cells |
| Q41647307 | Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells |
| Q72110976 | Growth of Primary Human Acute Lymphoblastic and Myeloblastic Leukemia in SCID Mice |
| Q58990568 | HIV and Kaposi's sarcoma in mice |
| Q45305157 | HIV induces thymus depletion in vivo |
| Q40321405 | HIV latency in the humanized BLT mouse |
| Q38270498 | HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q38905274 | HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model |
| Q35750948 | HIV-1 infection and pathogenesis in a novel humanized mouse model |
| Q33682963 | HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus |
| Q35716711 | HIV-1 replication and pathogenesis in the human thymus |
| Q34875979 | HIV-1 replication cycle |
| Q46062714 | HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo |
| Q37254475 | HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice |
| Q39014236 | HTLV-I hu-SCID mouse in the study of HTLV-I neurotropism |
| Q35161714 | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
| Q35831685 | Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model |
| Q40841674 | Hematology Testing in Mice |
| Q40907374 | Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia |
| Q36637556 | Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes |
| Q29396498 | Hematopoietic stem cell: self-renewal versus differentiation |
| Q34293470 | Hematopoietic stem cells can be CD34+ or CD34-. |
| Q27023434 | Hematopoietic-stem-cell-based gene therapy for HIV disease |
| Q55334102 | High human IgG levels in severe combined immunodeficient mouse reconstituted with human splenic tissues from patients with gastric cancer |
| Q35898011 | High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo |
| Q38808207 | High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis. |
| Q35877342 | High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells |
| Q34914050 | Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs |
| Q33681388 | Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice |
| Q36365868 | Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice |
| Q71639865 | Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency |
| Q72344503 | Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity |
| Q39003768 | Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo |
| Q40698897 | Human T-cell lineage development in foetal thymus-engrafted SCID mice |
| Q36164542 | Human adaptive immune system Rag2-/-gamma(c)-/- mice |
| Q33577374 | Human allograft rejection in humanized mice: a historical perspective |
| Q35647543 | Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. |
| Q40977104 | Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice |
| Q36030112 | Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication |
| Q45190392 | Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model |
| Q73379512 | Human fetal liver cells induce colonies in spleen of lethally irradiated mice |
| Q37012122 | Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice |
| Q38662832 | Human haematopoietic stem cell development: from the embryo to the dish |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q41823203 | Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus |
| Q34941696 | Human hematopoietic lineage commitment |
| Q36351925 | Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells |
| Q42254467 | Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells |
| Q36688402 | Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells |
| Q36773289 | Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo |
| Q41096686 | Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. |
| Q37517923 | Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse |
| Q36362448 | Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse |
| Q33784571 | Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo |
| Q33854319 | Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism |
| Q37047050 | Human immunodeficiency virus type 1 infection of neural xenografts |
| Q30305454 | Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication |
| Q33816889 | Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. |
| Q33822674 | Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo |
| Q43929735 | Human immunoglobulin production in immunodeficient mice: enhancement by immunosuppression of host and in vitro activation of human mononuclear cells |
| Q43233892 | Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice |
| Q37299847 | Human intrathymic development: a selective approach. |
| Q33786418 | Human lymphoblastoid CD4(+) T cells become permissive to macrophage-tropic strains of human immunodeficiency virus type 1 after passage into severe combined immunodeficient mice through in vivo upregulation of CCR5: in vivo dynamics of CD4(+) [...] |
| Q37981545 | Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells |
| Q36230932 | Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood |
| Q35446761 | Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model |
| Q57599053 | Human peripheral blood leukocytes transplanted on CB17 scid-scid mice are transferred to their offspring |
| Q73438385 | Human renal allograft rejection in the SCID/rat radiation chimera |
| Q41831183 | Human skin cells support thymus-independent T cell development |
| Q34572945 | Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo |
| Q34159789 | Human villous adenomas engrafted into scid mice survive for prolonged period without malignant transformation |
| Q45126833 | Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions |
| Q52932628 | Humanised mouse models in drug discovery for skin inflammation. |
| Q89755936 | Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative Medicine |
| Q92327815 | Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors |
| Q92881586 | Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
| Q40211555 | Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis |
| Q96690458 | Humanized Mouse Models for Evaluation of PSC Immunogenicity |
| Q39459609 | Humanized Mouse Models for Human Immunodeficiency Virus Infection. |
| Q38640208 | Humanized Mouse Models for Transplant Immunology |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q53568179 | Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. |
| Q33939330 | Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes |
| Q36756422 | Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year |
| Q26771440 | Humanized hemato-lymphoid system mice |
| Q92503390 | Humanized immune system mouse models: progress, challenges and opportunities |
| Q38838864 | Humanized mice for HIV and AIDS research |
| Q35027512 | Humanized mice for studying human leukocyte integrins in vivo |
| Q37179146 | Humanized mice for the study of infectious diseases |
| Q37049736 | Humanized mice for the study of type 1 diabetes and beta cell function |
| Q34607151 | Humanized mice in translational biomedical research |
| Q53592113 | Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. |
| Q28728527 | Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1 |
| Q39329450 | Humanized mice: A brief overview on their diverse applications in biomedical research. |
| Q26996648 | Humanized mice: novel model for studying mechanisms of human immune-based therapies |
| Q38196608 | Humanized mouse models in transplantation research |
| Q37089865 | Humanized mouse models of HIV infection |
| Q34533579 | Humanized mouse models of epstein-barr virus infection and associated diseases |
| Q36142747 | Humanized mouse models of human cytomegalovirus infection |
| Q92153241 | Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes |
| Q33941638 | Humanized mouse models to study human diseases |
| Q37019267 | Humoral Immunity in scid Mice Reconstituted with Cells from Immunoglobulin-Deficient or Normal Humans |
| Q37254488 | Humoral immunity in humanized mice: a work in progress |
| Q36972070 | IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice |
| Q36690000 | Identification of T cell-signaling pathways that stimulate latent HIV in primary cells |
| Q24656265 | Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood |
| Q21559618 | Identification of an astrovirus commonly infecting laboratory mice in the US and Japan |
| Q37289792 | Identification of newly isolated Babesia parasites from cattle in Korea by using the Bo-RBC-SCID mice |
| Q34308700 | Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells |
| Q41180599 | Immune deficiency in SCID mice |
| Q48556537 | Immune privilege and immunogenicity reside among different layers of the mouse cornea. 2000. |
| Q36553607 | Immune-Deficient Mice as Models for Human Hematopoietic Disease |
| Q33274792 | Immunization of hu-PBL–SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries |
| Q35846092 | Immunodeficient mice as hosts for hemoparasitic infections |
| Q37600286 | Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases |
| Q35765555 | Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development |
| Q43639080 | Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. |
| Q33814477 | Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice. |
| Q38675619 | Immunologic and pharmacologic concepts of monoclonal antibodies. |
| Q41505435 | Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice |
| Q35426801 | Impaired human responses to tetanus toxoid in vitamin A-deficient SCID mice reconstituted with human peripheral blood lymphocytes |
| Q36397429 | Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection |
| Q36365582 | Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes |
| Q35795065 | Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. |
| Q36601983 | Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary |
| Q39315707 | In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies |
| Q44001900 | In vitro preactivated human T cells engraft in SCID mice and migrate to murine lymphoid tissues |
| Q41932886 | In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication. |
| Q46069567 | In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood |
| Q35270138 | In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice |
| Q39100446 | In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus |
| Q39872035 | In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. |
| Q36515119 | In vivo platforms for analysis of HIV persistence and eradication |
| Q37340763 | In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides |
| Q35619845 | Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms. |
| Q43598504 | Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID) |
| Q41404314 | Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes |
| Q37247943 | Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice |
| Q40736018 | Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function |
| Q45970875 | Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. |
| Q35394786 | Infection of SCID mice with Mycobacterium leprae and control with antigen-activated "immune" human peripheral blood mononuclear cells |
| Q35100976 | Infection of human cytomegalovirus in cultured human gingival tissue |
| Q35788681 | Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis |
| Q39134077 | Influence of human myasthenia gravis thymus on the differentiation of human cord blood stem cells in SCID mice |
| Q31115718 | Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies |
| Q28368330 | Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320 |
| Q36229284 | Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1 |
| Q74261294 | Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells |
| Q36922569 | Isolation of a candidate human hematopoietic stem-cell population |
| Q42541770 | Kidney transplant revisited (1990) |
| Q38263295 | Latest animal models for anti-HIV drug discovery |
| Q27322228 | Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations |
| Q53302987 | Leukaemia stem cells and the evolution of cancer-stem-cell research. |
| Q73397027 | Limitation of Hu-PBL-scid mouse model in direct application to immunotoxicity assessment |
| Q34237806 | Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans |
| Q35981519 | Limited role for the thymus in SIV pathogenesis |
| Q73043963 | Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice |
| Q42092076 | Long-term human hematopoiesis in the SCID-hu mouse |
| Q34131709 | Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep |
| Q92366030 | Long-term survival and differentiation of human thymocytes in human thymus-grafted immunodeficient mice |
| Q44245848 | Long-term survival of human spermatogonial stem cells in mouse testes |
| Q35494359 | Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes |
| Q73415909 | Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras |
| Q42768290 | Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells |
| Q36232070 | Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation |
| Q36436908 | Lymphotropic Viruses as Etiologic Agents of Lymphoma |
| Q67599021 | MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells |
| Q35585979 | Macrophages prevent human red blood cell reconstitution in immunodeficient mice |
| Q37624015 | Man-made antibodies |
| Q38167666 | Manipulation of hematopoietic stem cells for regenerative medicine |
| Q33793274 | Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells |
| Q72769524 | Mature helper T cell requirement for immunoglobulin production by neonatal native B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice |
| Q39874671 | Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. |
| Q35889286 | Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection |
| Q37853939 | Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies |
| Q35891603 | Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation |
| Q37126312 | Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. |
| Q36299357 | Mice in the world of stem cell biology |
| Q34730602 | Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy |
| Q21146658 | Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection |
| Q34920166 | Mice with human immune system components as in vivo models for infections with human pathogens |
| Q92511043 | Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State |
| Q40497129 | Modeling human retroviral pathogenesis and antiretroviral gene therapy in the SCID mouse |
| Q38164593 | Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation |
| Q49914671 | Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches |
| Q34263657 | Molecular Characterization, Reactivation, and Depletion of Latent HIV |
| Q39820667 | Molecular biology and pathogenesis of animal lentivirus infections. |
| Q35173841 | Molecular biology of hematopoietic stem cells |
| Q24313183 | Molecular cloning and characterization of WP34, a phosphorylated human lymphocyte differentiation and activation antigen |
| Q37755851 | Monoclonal antibodies in diagnosis and therapy |
| Q38798188 | Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges |
| Q38016511 | Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma |
| Q38937610 | Mouse models for pre-clinical drug testing in leukemia |
| Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
| Q34590684 | Mouse models with human immunity and their application in biomedical research |
| Q59478476 | Multiple genetically engineered humanized microenvironments in a single mouse |
| Q38795321 | Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis |
| Q37077665 | Murine models for HIV vaccination and challenge. |
| Q40946526 | Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice |
| Q73086701 | NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors |
| Q36622723 | Neoplastic stem cells: a novel therapeutic target in clinical oncology |
| Q38004015 | New approaches to expand hematopoietic stem and progenitor cells |
| Q37337138 | No irradiation required: The future of humanized immune system modeling in murine hosts |
| Q37034635 | Nonprimate models of HIV-1 infection and pathogenesis |
| Q89965644 | Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART -/- IL2RG -/Y SCID Pigs |
| Q58987031 | Novel HIV systems |
| Q37084504 | Novel humanized murine models for HIV research |
| Q43496456 | Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells |
| Q36931065 | Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine |
| Q35749938 | Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models |
| Q37254483 | Overcoming current limitations in humanized mouse research |
| Q35035610 | PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads |
| Q33863465 | Paradigm shifts in stem-cell biology |
| Q33492216 | Paradoxical enhancement of tumor growth in mice with severe combined immunodeficiency which produce a human immunoglobulin G reactive against tumor cells |
| Q33716675 | Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. |
| Q30305455 | Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice |
| Q80031735 | Perforin-independent rejection of transplanted human stem cells |
| Q73550868 | Perinatal induction of immunotolerance to cardiac and pulmonary allografts |
| Q45874365 | Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors |
| Q40064566 | Persistent infection of normal mice with human immunodeficiency virus |
| Q102144611 | Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo |
| Q53495266 | Phenotypic and Functional Studies of Human Peripheral Blood Lymphocytes Engrafted in scid Mice |
| Q38502873 | Positive regulatory gamma delta T cells in contact sensitivity: augmented responses by in vivo treatment with anti-gamma delta monoclonal antibody, or anti-V gamma 5 or V delta 4. |
| Q35128255 | Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice. |
| Q35605784 | Potential of embryonic and adult stem cells in vitro. |
| Q36890224 | Potential of the scid mouse as a host for human tumors |
| Q37019281 | Preclinical Evaluation of Human Hematolymphoid Function in the SCID-hu Mouse |
| Q39339749 | Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells |
| Q54127314 | Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice. |
| Q39878783 | Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain |
| Q41756541 | Production of a diverse repertoire of human antibodies in genetically engineered mice |
| Q41610889 | Production of human immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues |
| Q32103173 | Production of human monoclonal antibodies in SCID mouse |
| Q44563926 | Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study |
| Q38409791 | Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy |
| Q33795512 | Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals |
| Q30448634 | R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression |
| Q33650466 | R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. |
| Q28592133 | RAG-1-deficient mice have no mature B and T lymphocytes |
| Q84068289 | Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution |
| Q34975395 | Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γcnullMice: Suppression by an Inhibitor against NF-κB |
| Q40329064 | Rapid expression of human immunodeficiency virus following activation of latently infected cells |
| Q54936296 | Rapid growth and spontaneous metastasis of human germinal tumors ectopically transplanted into scid (severe combined immunodeficiency) and scid-nudestreaker mice. |
| Q40043073 | Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. |
| Q35025116 | Rats produced by interspecies spermatogonial transplantation in mice and in vitro microinsemination. |
| Q51410352 | Rebooting Human Immunology. |
| Q34195247 | Recapitulation of normal and abnormal BB rat immune system development in scid mouse/rat lymphohemopoietic chimeras |
| Q92543466 | Recent Advances in Allergy Research Using Humanized Mice |
| Q37254480 | Recent advances in humanized mice: accelerating the development of an HIV vaccine |
| Q36375811 | Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells |
| Q55343646 | Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1. |
| Q58178129 | Reconstitution of Immunological Imbalance in SCID Mice Given Tonsillar Mononuclear Cells from Patients with IgA Nephropathy |
| Q38498361 | Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model. |
| Q39595155 | Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy |
| Q28488527 | Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice |
| Q45885467 | Reduced tumorigenicity of human gastric carcinoma cells engineered to produce IL-2 in SCID mice reconstituted with peripheral blood cells from cancer patients |
| Q30176097 | Regions of human immunodeficiency virus type 1 nef required for function in vivo |
| Q44378836 | Regulation of Maternal–Fetal Virus Transmission in Immunologically Reconstituted SCID Mice Infected with Lactate Dehydrogenase-Elevating Virus |
| Q37600607 | Renaissance for mouse models of human hematopoiesis and immunobiology |
| Q35856279 | Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice |
| Q36633938 | Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity |
| Q36175538 | Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. |
| Q54272403 | Responses to larval Taenia taeniaeformis in mice with severe combined immunodeficiency (scid). |
| Q31909374 | Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo |
| Q35604723 | Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow |
| Q45866942 | RevM10-Mediated Inhibition of HIV-1 Replication in Chronically Infected T Cells |
| Q39879985 | RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication |
| Q39820681 | SCID mice and the study of parasitic disease |
| Q35646248 | SCID mice in the study of human autoimmune diseases |
| Q73584258 | SCID mouse models: more than furry flasks |
| Q36951729 | SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection |
| Q33851415 | Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus |
| Q24669589 | Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates |
| Q36651958 | Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus |
| Q34255262 | Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation |
| Q40129737 | Simultaneous detection of multiple pathogens by multiplex PCR coupled with DNA biochip hybridization |
| Q34356549 | Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue |
| Q84696524 | Specific human IgE response after immunization with birch pollen in scid mice transplanted with human peripheral blood mononuclear cells—A model for human allergy? |
| Q47683086 | Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective |
| Q35811283 | Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology |
| Q34344216 | Stem cell gene transfer--efficacy and safety in large animal studies. |
| Q36362598 | Stem cell research: future implications for internal medicine |
| Q41689634 | Stem cells in chronic myelogenous leukemia |
| Q34565274 | Stem cells in regenerative biology and medicine |
| Q40438232 | Stem cells, clonal progenitors, and commitment to the three lymphocyte linages: T, B, and NK Cells |
| Q26849806 | Studies of retroviral infection in humanized mice |
| Q42338715 | Studying human immunology and immunopathology in humanized mice transplanted with human lymphoid tissues and immune cells |
| Q36229754 | Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens |
| Q41632290 | Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody |
| Q40654989 | Successful multilineage engraftment of human cord blood cells in pigs after in utero transplantation |
| Q36511820 | Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop |
| Q77212598 | Surgical technique for vascularized thymus transplantation in mice |
| Q41670554 | Syncytium Formation in Cultured Human Lymphoid Tissue: Fusion of Implanted HIV Glycoprotein 120/41-Expressing Cells with Native CD4+Cells |
| Q72873376 | Synergetic effect of interleukin-2 and cellular cytotoxicity against a novel tumor-associated carbohydrate antigen Le(a)/Le(a) (dimeric Le(a)) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID mice |
| Q35830294 | Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits |
| Q28472590 | Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice |
| Q92008485 | T Lymphocyte Development and Activation in Humanized Mouse Model |
| Q45789448 | T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice |
| Q34984536 | T lineage differentiation from human embryonic stem cells |
| Q36361803 | T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells |
| Q35872456 | T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. |
| Q37867570 | T-cell receptor and autoimmune disease |
| Q37567989 | Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo |
| Q77977537 | The CD4 Loss in AIDS Patients is not Immunopathologically Mediated |
| Q33650192 | The E. Donnall Thomas lecture: normal and neoplastic stem cells |
| Q35112331 | The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE |
| Q46121365 | The Response to Burn Injury in Mice With Human Hematolymphoid Systems |
| Q40788237 | The SCID mouse: relevance as an animal model system for studying human disease. |
| Q41546977 | The SCID-hu mouse as a model for HIV-1 infection |
| Q41521953 | The SCID-hu mouse: an in vivo model for HIV-1 infection in humans |
| Q47888689 | The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases |
| Q55078034 | The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer. |
| Q36361449 | The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-beige-nude-xid mice is associated with the reconstitution of the murine immune system |
| Q34012447 | The development of the immune system during pregnancy and early life |
| Q34134909 | The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. |
| Q39036388 | The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes |
| Q34926717 | The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice |
| Q44582551 | The fate of human peripheral blood lymphocytes after transplantation into SCID mice |
| Q36229985 | The immunodeficient scid mouse as a model for human lymphatic filariasis |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q49062938 | The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection |
| Q37900419 | The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models |
| Q40876696 | The new antibody technologies. |
| Q36951804 | The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases |
| Q35276631 | The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention |
| Q48504672 | The road ended up at stem cells |
| Q70527020 | The role of natural antibodies and ABO (H) blood groups in transplantation of human lymphoid cells into mice |
| Q25257167 | The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. |
| Q41233084 | The use of SCID mice in biotechnology and as a model for human disease |
| Q40712126 | The use of fetal tissue for therapeutic applications |
| Q54244413 | The use of humanized mice for studies of viral pathogenesis and immunity. |
| Q35206268 | The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment |
| Q37346027 | The utilization of humanized mouse models for the study of human retroviral infections |
| Q41102652 | Therapeutic Human Antibodies Derived from PCR Amplification of B‐Cell Variable Regions |
| Q42001743 | Thymic selection of the human T cell receptor V beta repertoire in SCID-hu mice |
| Q45854426 | Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils |
| Q33956786 | Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation |
| Q46546302 | Today's SCID-hu mouse |
| Q104617072 | Tracking HIV Rebound following Latency Reversal Using Barcoded HIV |
| Q34565309 | Traditional and molecular techniques for the study of emerging bacterial diseases: one laboratory's perspective |
| Q36353439 | Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice |
| Q29398132 | Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients |
| Q35764161 | Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints |
| Q72840889 | Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID) |
| Q45883782 | Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy |
| Q26772335 | Translating Treg Therapy in Humanized Mice |
| Q73109454 | Transplantation and chimera as extended self |
| Q47587003 | Transplantation and growth characteristics of human fetal lymph node in immunodeficient mice |
| Q37019276 | Transplantation of Normal and Leukemic Human Bone Marrow into Immune-Deficient Mice: Development of Animal Models for Human Hematopoiesis |
| Q41020244 | Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis |
| Q28326886 | Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine |
| Q35845405 | Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice |
| Q40465763 | T‐Cell Repertoires in Health and Diseasea |
| Q60267505 | U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies |
| Q36231592 | Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis |
| Q35738486 | Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases |
| Q95841651 | Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence |
| Q34582987 | Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity |
| Q35783479 | Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection |
| Q37354186 | Use of humanized severe combined immunodeficient mice for human vaccine development |
| Q40497058 | Use of severe combined immunodeficient mice to measure developmental potential of B-cell precursors. |
| Q35123273 | Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds |
| Q37374872 | Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. |
| Q36621632 | Using the BLT humanized mouse as a stem cell based gene therapy tumor model |
| Q28469262 | Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals |
| Q41710742 | Viral pathogenesis and immunity within the thymus |
| Q36201405 | What we are learning on HTLV-1 pathogenesis from animal models |
| Q74072877 | Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function |
| Q40928493 | Xenograft model systems for human melanoma |
| Q36799846 | Xenograft models for the preclinical evaluation of new therapies in acute leukemia |
| Q77070950 | Xenotransplantation |
| Q27013024 | Xenotransplantation models to study the effects of toxicants on human fetal tissues |
| Q86848619 | [Development of immunodeficient mice/humanized mouse models and their applications in hematology research] |
| Q53447499 | [Transgenic human thymopoiesis from retrovirally transduced umbilical cord blood hematopoietic stem cells: experimental studies in the SCID-hu mouse] |
| Q36466103 | hu-PBL-SCID Mice: A Model for Human Immune Function, AIDS, and Lymphomagenesis |
Search more.